200 Granville Street
Suite 2820
Vancouver, BC V6C 1S4
Canada
604 336 7906
https://www.aequuspharma.ca
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 12
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Douglas Glen Janzen | Chairman, CEO & President | 151.85k | N/A | 1969 |
Ms. Ann Fehr CGA, CPA | CFO & Corporate Secretary | 100.23k | N/A | 1969 |
Mr. Grant Larsen | Chief Commercial Officer | 180.08k | N/A | N/A |
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Aequus Pharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.